Results 131 to 139 of about 6,519 (139)

Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]

open access: yesLancet Reg Health Am
Sauré D   +10 more
europepmc   +1 more source

[Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants]. [PDF]

open access: yesRev Esp Quimioter
Rodríguez-Fernández R   +7 more
europepmc   +1 more source

[Environmental medicine and AI, migration, and emerging and reemerging diseases in Mexico]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Rivera-Silva G   +2 more
europepmc   +1 more source

Geopharmacosurveillance of reporting rates of events supposedly attributable to vaccination or immunization against COVID-19. [PDF]

open access: yesRev Lat Am Enfermagem
Barbosa TCP   +5 more
europepmc   +1 more source

Status of the national immunization technical advisory groups in the Americas: recommendations for improvement. [PDF]

open access: yesRev Panam Salud Publica
Betancourt-Cravioto M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy